Rapid diagnostic test for simultaneous detection of influenza A/B and coronavirus antigens from nasopharyngeal or oropharyngeal specimens. CLIA-waived immunofluorescence assay enabling point-of-care results within minutes for respiratory pathogen screening and patient triage.
Manufactured by
Healgen Scientific LLC
Houston, TX, United States
Healgen Scientific, a wholly owned subsidiary of Zhejiang Orient Gene Biotech Co.,Ltd, develops, manufactures and commercializes in-vitro diagnostic test systems worldwide. Our product portfolio spans multiple testing categories and analytes to meet various clinical and laboratory needs. Our testing platforms include rapid testing, molecular diagnostics, and multiplex flow cytometry. Since our inception in 2007, we have strived to develop devices that meet and exceed industry standards. The manufacturing process is supported by our interactive and highly-skilled Research and Development team, who are actively redefining the efficiency and design of our products. Our ambition is worldwide, and we currently provide products to customers in: USA, Europe, Middle-East, South Asia, Africa and Latin America for a total of 80+ countries. Our mission is to provide premier support to our distributors and partners. We have a flexible strategy on business cooperation, where we offer OEM options. Our success is supported by our professional personnel and good manufacturing practice. Healgen™ and DIAGNOSTAR™ are registered trademarks of Healgen Scientific LLC. These are produced and manufactured by Healgen Scientific LLC.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 1 relevant product
Biopanda Reagents
United Kingdom · 3 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
69 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 117 closest product alternatives
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid immunochromatographic test for simultaneous detection of COVID-19 and influenza A/B antigens from respiratory specimens. Delivers results in 15-20 minutes, enabling quick differential diagnosis in clinical and point-of-care settings. Single-use test cassette with high sensitivity and specificity for viral antigen identification.
Biopanda Reagents · United Kingdom
An immunochromatographic assay for qualitative detection of SARS-CoV-2 nucleocapsid protein and Influenza A+B virus antigens in nasal and nasopharyngeal swab samples. It is intended to assist in the diagnosis of SARS-CoV-2 and Influenza A+B infections in conjunction with other tests.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
114 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products